A Study to Evaluate the Tolerability, Safety and Efficacy of GNR-097 Gene Therapy in Pediatric Patients With Duchenne Muscular Dystrophy
Clinical trial NCT07673809 · RECRUITING
Trial details
- NCT number
- NCT07673809
- Sponsor
- AO GENERIUM
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-30
- Primary completion
- 2029-08-02
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.